Biologics Spine Top Stories DiscGenics Announces the International Journal of Spine Surgery Has Published Results from an FDA-Approved Study of an Allogeneic Disc Progenitor Cell Therapy for the Treatment of Adults with Lumbar Disc Degeneration byJosh SandbergJuly 9, 2024
Financial Spine Top Stories Centinel Spine® Record prodisc® Total Disc Replacement Growth of 55% in 2023 Sets the Foundation for Continued Growth in 2024 and Beyond byJosh SandbergJanuary 31, 2024
Biologics Spine Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA byJosh SandbergDecember 27, 2023
Biologics Spine Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc byJosh SandbergNovember 29, 2023
Biologics Spine Cerapedics Reinforces Commitment to Level 1 Evidence with Long-Term Results from Six-Year Pivotal IDE Cervical Study Demonstrating 98.6% Spine Fusion Rates in Patients Treated With i-FACTOR® byJosh SandbergOctober 17, 2023
Neuro Spine Relievant Medsystems Announces Pooled 4-Year Outcomes Validating Long-Term Effectiveness of the Intracept Procedure byJosh SandbergJuly 20, 2023
Spine Viseon Inc. Announces Preliminary Results of Surgeon Experience Database Utilizing MaxView® System During Minimally Invasive Lateral Spine Surgery byJosh SandbergNovember 30, 2022
Recon Top Stories Zimmer Biomet Announces One-Year Data from mymobility® Clinical Study at 2022 AAHKS Annual Meeting byJosh SandbergNovember 7, 2022
Spine Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using ZIP™ MIS Interspinous Fusion System byChris StewartOctober 27, 2022
